blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2968437

EP2968437 - CASEIN HYDROLYSATE FOR USE IN TREATING INFLAMMATORY DISEASES [Right-click to bookmark this link]
Former [2016/03]REDUCING PROINFLAMMATORY RESPONSE
[2020/14]
StatusNo opposition filed within time limit
Status updated on  04.06.2021
Database last updated on 03.09.2024
FormerThe patent has been granted
Status updated on  26.06.2020
FormerGrant of patent is intended
Status updated on  07.04.2020
FormerExamination is in progress
Status updated on  30.06.2017
Most recent event   Tooltip27.04.2024Lapse of the patent in a contracting state
New state(s): MK
published on 29.05.2024  [2024/22]
Applicant(s)For all designated states
MJN U.S. Holdings LLC
2400 West Lloyd Expressway
Evansville, Indiana 47721 / US
[2020/21]
Former [2017/50]For all designated states
MJN U.S. Holdings LLC
225 North Canal Street
25th Floor
Chicago, Illinois 60606 / US
Former [2016/03]For all designated states
MJN U.S. Holdings, LLC
2701 Patriot Boulevard, 4th Floor
Glenview, IL 60026 / US
Inventor(s)01 / HONDMANN, Dirk
190 Birch Street
Winnetka, Illinois 60093 / US
02 / VAN TOL, Eric A.F.
Roemer Visscherstraat 62
NL-6824 MZ Arnhem / NL
03 / GROSS, Gabriele
Mesdagstraat 46
NL-6521 MR Nijmegen / NL
04 / SCHOEMAKER, Marieke H.
Kastanjelaan 54
3911 BH Rhenen / NL
05 / LAMBERS, Teartse Tim
Fruitlaan 5
NL-6515 CA Nijmegen / NL
 [2016/03]
Representative(s)Cawdell, Karen Teresa, et al
Reckitt Benckiser
Corporate Services Limited
Legal Department - Patents Group
Dansom Lane
Hull HU8 7DS / GB
[2020/31]
Former [2016/03]V.O.
P.O. Box 87930
2508 DH Den Haag / NL
Application number, filing date14714100.611.03.2014
[2016/03]
WO2014US23637
Priority number, dateUS20131383853915.03.2013         Original published format: US201313838539
[2016/03]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014150571
Date:25.09.2014
Language:EN
[2014/39]
Type: A1 Application with search report 
No.:EP2968437
Date:20.01.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 25.09.2014 takes the place of the publication of the European patent application.
[2016/03]
Type: B1 Patent specification 
No.:EP2968437
Date:29.07.2020
Language:EN
[2020/31]
Search report(s)International search report - published on:EP25.09.2014
ClassificationIPC:A61K38/01, A61K31/702, A61K31/202, A61P29/00, A61P3/10, A61P1/00
[2016/03]
CPC:
A61K31/202 (EP,US); A61K38/1709 (US); A61K31/702 (EP,US);
A61K35/741 (US); A61K38/018 (EP,US); A61P1/00 (EP);
A61P29/00 (EP); A61P3/00 (EP); A61P3/10 (EP);
A61P37/00 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/03]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:KASEINHYDROLYSAT ZUR VERWENDUNG BEI DER BEHANDLUNG VON ENTZÜNDUNGSKRANKHEITEN[2020/14]
English:CASEIN HYDROLYSATE FOR USE IN TREATING INFLAMMATORY DISEASES[2020/14]
French:HYDROLYSAT DE CASÉINE POUR L'UTILISATION DANS LE TRAITEMENT DES MALADIES INFLAMMATOIRES[2020/14]
Former [2016/03]REDUZIERUNG ENTZÜNDUNGSFÖRDERNDER REAKTIONEN
Former [2016/03]REDUCING PROINFLAMMATORY RESPONSE
Former [2016/03]RÉDUCTION D'UNE RÉPONSE PRO-INFLAMMATOIRE
Entry into regional phase25.08.2015National basic fee paid 
25.08.2015Designation fee(s) paid 
25.08.2015Examination fee paid 
Examination procedure25.08.2015Examination requested  [2016/03]
07.04.2016Amendment by applicant (claims and/or description)
04.07.2017Despatch of a communication from the examining division (Time limit: M06)
13.02.2018Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
17.04.2018Reply to a communication from the examining division
10.12.2018Despatch of a communication from the examining division (Time limit: M06)
13.05.2019Reply to a communication from the examining division
08.04.2020Communication of intention to grant the patent
12.06.2020Fee for grant paid
12.06.2020Fee for publishing/printing paid
12.06.2020Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  04.07.2017
Opposition(s)30.04.2021No opposition filed within time limit [2021/27]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
17.04.2018Request for further processing filed
17.04.2018Full payment received (date of receipt of payment)
Request granted
30.04.2018Decision despatched
Fees paidRenewal fee
10.03.2016Renewal fee patent year 03
10.03.2017Renewal fee patent year 04
13.03.2018Renewal fee patent year 05
13.03.2019Renewal fee patent year 06
12.03.2020Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU11.03.2014
AL29.07.2020
AT29.07.2020
CY29.07.2020
CZ29.07.2020
DK29.07.2020
EE29.07.2020
FI29.07.2020
HR29.07.2020
LT29.07.2020
LV29.07.2020
MC29.07.2020
MK29.07.2020
PL29.07.2020
RO29.07.2020
RS29.07.2020
SE29.07.2020
SI29.07.2020
SK29.07.2020
SM29.07.2020
BG29.10.2020
NO29.10.2020
GR30.10.2020
IS29.11.2020
PT30.11.2020
LU11.03.2021
BE31.03.2021
CH31.03.2021
LI31.03.2021
[2024/22]
Former [2023/30]HU11.03.2014
AL29.07.2020
AT29.07.2020
CY29.07.2020
CZ29.07.2020
DK29.07.2020
EE29.07.2020
FI29.07.2020
HR29.07.2020
LT29.07.2020
LV29.07.2020
MC29.07.2020
PL29.07.2020
RO29.07.2020
RS29.07.2020
SE29.07.2020
SI29.07.2020
SK29.07.2020
SM29.07.2020
BG29.10.2020
NO29.10.2020
GR30.10.2020
IS29.11.2020
PT30.11.2020
LU11.03.2021
BE31.03.2021
CH31.03.2021
LI31.03.2021
Former [2023/27]HU11.03.2014
AL29.07.2020
AT29.07.2020
CZ29.07.2020
DK29.07.2020
EE29.07.2020
FI29.07.2020
HR29.07.2020
LT29.07.2020
LV29.07.2020
MC29.07.2020
PL29.07.2020
RO29.07.2020
RS29.07.2020
SE29.07.2020
SI29.07.2020
SK29.07.2020
SM29.07.2020
BG29.10.2020
NO29.10.2020
GR30.10.2020
IS29.11.2020
PT30.11.2020
LU11.03.2021
BE31.03.2021
CH31.03.2021
LI31.03.2021
Former [2022/34]AL29.07.2020
AT29.07.2020
CZ29.07.2020
DK29.07.2020
EE29.07.2020
FI29.07.2020
HR29.07.2020
LT29.07.2020
LV29.07.2020
MC29.07.2020
PL29.07.2020
RO29.07.2020
RS29.07.2020
SE29.07.2020
SI29.07.2020
SK29.07.2020
SM29.07.2020
BG29.10.2020
NO29.10.2020
GR30.10.2020
IS29.11.2020
PT30.11.2020
LU11.03.2021
BE31.03.2021
CH31.03.2021
LI31.03.2021
Former [2022/11]AL29.07.2020
AT29.07.2020
CZ29.07.2020
DK29.07.2020
EE29.07.2020
FI29.07.2020
HR29.07.2020
LT29.07.2020
LV29.07.2020
MC29.07.2020
PL29.07.2020
RO29.07.2020
RS29.07.2020
SE29.07.2020
SI29.07.2020
SK29.07.2020
SM29.07.2020
BG29.10.2020
NO29.10.2020
GR30.10.2020
IS29.11.2020
PT30.11.2020
LU11.03.2021
CH31.03.2021
LI31.03.2021
Former [2022/09]AL29.07.2020
AT29.07.2020
CZ29.07.2020
DK29.07.2020
EE29.07.2020
FI29.07.2020
HR29.07.2020
LT29.07.2020
LV29.07.2020
MC29.07.2020
PL29.07.2020
RO29.07.2020
RS29.07.2020
SE29.07.2020
SI29.07.2020
SK29.07.2020
SM29.07.2020
BG29.10.2020
NO29.10.2020
GR30.10.2020
IS29.11.2020
PT30.11.2020
LU11.03.2021
Former [2021/45]AL29.07.2020
AT29.07.2020
CZ29.07.2020
DK29.07.2020
EE29.07.2020
FI29.07.2020
HR29.07.2020
LT29.07.2020
LV29.07.2020
MC29.07.2020
PL29.07.2020
RO29.07.2020
RS29.07.2020
SE29.07.2020
SI29.07.2020
SK29.07.2020
SM29.07.2020
BG29.10.2020
NO29.10.2020
GR30.10.2020
IS29.11.2020
PT30.11.2020
Former [2021/36]AL29.07.2020
AT29.07.2020
CZ29.07.2020
DK29.07.2020
EE29.07.2020
FI29.07.2020
HR29.07.2020
LT29.07.2020
LV29.07.2020
PL29.07.2020
RO29.07.2020
RS29.07.2020
SE29.07.2020
SI29.07.2020
SK29.07.2020
SM29.07.2020
BG29.10.2020
NO29.10.2020
GR30.10.2020
IS29.11.2020
PT30.11.2020
Former [2021/28]AL29.07.2020
AT29.07.2020
CZ29.07.2020
DK29.07.2020
EE29.07.2020
FI29.07.2020
HR29.07.2020
LT29.07.2020
LV29.07.2020
PL29.07.2020
RO29.07.2020
RS29.07.2020
SE29.07.2020
SK29.07.2020
SM29.07.2020
BG29.10.2020
NO29.10.2020
GR30.10.2020
IS29.11.2020
PT30.11.2020
Former [2021/25]AL29.07.2020
AT29.07.2020
CZ29.07.2020
DK29.07.2020
EE29.07.2020
FI29.07.2020
HR29.07.2020
LT29.07.2020
LV29.07.2020
PL29.07.2020
RO29.07.2020
RS29.07.2020
SE29.07.2020
SM29.07.2020
BG29.10.2020
NO29.10.2020
GR30.10.2020
IS29.11.2020
PT30.11.2020
Former [2021/23]AT29.07.2020
CZ29.07.2020
DK29.07.2020
EE29.07.2020
FI29.07.2020
HR29.07.2020
LT29.07.2020
LV29.07.2020
PL29.07.2020
RO29.07.2020
RS29.07.2020
SE29.07.2020
SM29.07.2020
BG29.10.2020
NO29.10.2020
GR30.10.2020
IS29.11.2020
PT30.11.2020
Former [2021/22]AT29.07.2020
CZ29.07.2020
DK29.07.2020
EE29.07.2020
FI29.07.2020
HR29.07.2020
LT29.07.2020
LV29.07.2020
PL29.07.2020
RO29.07.2020
RS29.07.2020
SE29.07.2020
BG29.10.2020
NO29.10.2020
GR30.10.2020
IS29.11.2020
PT30.11.2020
Former [2021/21]AT29.07.2020
DK29.07.2020
FI29.07.2020
HR29.07.2020
LT29.07.2020
LV29.07.2020
PL29.07.2020
RS29.07.2020
SE29.07.2020
BG29.10.2020
NO29.10.2020
GR30.10.2020
IS29.11.2020
PT30.11.2020
Former [2021/10]AT29.07.2020
FI29.07.2020
HR29.07.2020
LT29.07.2020
LV29.07.2020
PL29.07.2020
RS29.07.2020
SE29.07.2020
BG29.10.2020
NO29.10.2020
GR30.10.2020
IS29.11.2020
PT30.11.2020
Former [2021/09]AT29.07.2020
FI29.07.2020
LT29.07.2020
SE29.07.2020
BG29.10.2020
NO29.10.2020
GR30.10.2020
PT30.11.2020
Former [2021/08]FI29.07.2020
LT29.07.2020
SE29.07.2020
BG29.10.2020
NO29.10.2020
PT30.11.2020
Former [2021/07]FI29.07.2020
LT29.07.2020
NO29.10.2020
Cited inInternational search[XY]WO2005081628  (CHAY 13 MEDICAL RES GROUP N V [NL], et al) [X] 1-3 * abstract * * page 16, lines 15-21 * * page 63, lines 10-14 * * claims 1,7,8 * * sequences 581,1810,1838 * [Y] 1-13;
 [XY]US2008096794  (BOEHM GUNTHER [DE], et al) [X] 1,3,8,10-13 * abstract * * paragraphs [0013] , [0017] , [0018] , [0021] , [0022] , [0026] , [0027] , [0028] , [0029] , [0048] , [0051] * * example 1 * * claims 2,4-6 * [Y] 1-13;
 [XY]US2009075904  (BOOTS JAN-WILLEM PIETER [NL]) [X] 1-3 * abstract * * paragraphs [0011] , [0013] , [0014] , [0015] , [0025] , [0030] , [0032] , [0037] * * sequence 35 * * claims 21,28 * [Y] 1-13;
 [XY]EP2332428  (MEAD JOHNSON NUTRITION CO [US]) [X] 1-6,8,12,13 * paragraphs [0012] , [0017] , [0018] , [0023] - [0025] - [0028] , [0029] , [0033] , [0034] , [0036] , [0037] , [0041] , [0042] * * figure 8 * [Y] 1-13;
 [Y]  - MAO X Y ET AL, "Free-radical-scavenging and anti-inflammatory effect of yak milk casein before and after enzymatic hydrolysis", FOOD CHEMISTRY, ELSEVIER LTD, NL, vol. 126, no. 2, ISSN 0308-8146, (20110515), pages 484 - 490, (20101222), XP027571813 [Y] 1-13 * abstract * * page 485, columns 3,5 * * page 486, column 7 * * page 489, columns 2,3 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.